TickerFacts.

Company research / ICUI

ICU Medical Inc (ICUI)

Build a valuation ↗↓ Download CSV

SEC name ICU MEDICAL INC/DE · CIK 0000883984 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, ICU Medical Inc reported revenue of $2.23B. Revenue fell 6.3% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $2.16B.

Key ratios (year ended 2025-12-31)

36.8%
Gross margin
1.9%
Operating margin
0.0%
Net margin
0.0%
Return on year-end equity
-6.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-03

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$2.16B$2.23B$2.38B$2.26B$2.28B$1.32B$1.27B$1.27B$1.40B$1.29B$379.37M
Cost of Revenuen/a$1.41B$1.56B$1.52B$1.58B$824.82M$809.51M$794.34M$830.01M$866.52M$177.97M
Gross Profit$845.14M$822.04M$824.78M$739.87M$697.76M$491.49M$461.50M$471.86M$570.03M$426.10M$201.40M
R&D Expense$86.32M$87.50M$88.61M$85.34M$92.98M$47.50M$42.95M$48.61M$52.87M$51.25M$12.96M
Operating Income$72.06M$42.83M$42.96M$22.82M-$42.90M$123.25M$98.16M$107.36M$29.76M-$13.29M$82.94M
Depreciation & Amortization$201.27M$200.74M$219.51M$228.77M$235.15M$89.70M$85.63M$76.92M$74.73M$66.57M$19.05M
EBITDA$273.33M$243.57M$262.48M$251.60M$192.25M$212.94M$183.79M$184.28M$104.49M$53.27M$101.99M
Net Income$30.09M$732.0K-$117.69M-$29.66M-$74.29M$103.14M$86.87M$101.03M$28.79M$68.64M$63.08M
EPS (Diluted)n/a$0.03-$4.83-$1.23-$3.11$4.74$4.02$4.69$1.33$3.29$3.66
Total Assets$3.97B$4.05B$4.20B$4.38B$4.52B$1.88B$1.76B$1.69B$1.59B$1.50B$704.69M
Shareholders' Equity$2.15B$2.12B$1.97B$2.12B$2.09B$1.62B$1.50B$1.38B$1.26B$1.20B$660.15M
Cash & Equivalentsn/an/an/an/a$208.78M$552.83M$396.10M$268.67M$344.78M$290.07M$445.08M
Operating Cash Flow$236.37M$179.85M$204.03M$166.20M-$62.13M$267.54M$222.75M$101.92M$160.22M$154.42M$89.94M
Capital Expenditures$83.54M$88.04M$79.37M$83.89M$90.31M$68.54M$92.00M$97.31M$92.72M$74.48M$23.36M
Free Cash Flow$152.83M$91.80M$124.66M$82.31M-$152.44M$199.00M$130.75M$4.61M$67.50M$79.94M$66.58M
Share Repurchasesn/a$8.77M$11.99M$9.35M$10.88M$8.34M$12.88M$18.64M$6.25M$4.06M$17.23M
Shares Outstanding25.01M24.69M24.52M24.14M23.99M21.28M21.06M20.74M20.49M20.21M16.34M
Weighted Average Diluted Sharesn/a24.90M24.39M24.09M23.87M21.78M21.59M21.55M21.60M20.86M17.25M
EPS (Basic)n/a$0.03-$4.83-$1.23-$3.11$4.86$4.16$4.90$1.41$3.50$3.90

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView